Skip to main content
SpringerLink
Log in

Liraglutide increases risk of biliary and gallbladder disorders

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nauck MA, et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care : 9 Aug 2019. Available from: URL: https://doi.org/10.2337/dc19-0415

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liraglutide increases risk of biliary and gallbladder disorders. Reactions Weekly 1768, 9 (2019). https://doi.org/10.1007/s40278-019-66694-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-66694-3

Search

Navigation